CSPG4: A Target for Selective Delivery of Human Cytolytic Fusion Proteins and TRAIL

por Jordaan, Sandra, Chetty, Shivan, Mungra, Neelakshi, Koopmans, Iris, van Bommel, Peter E., Helfrich, Wijnand, Barth, Stefan
Publicado 2017

Bispecific antibody approach for EGFR-directed blockade of the CD47-SIRPα “don’t eat me” immune checkpoint promotes neutrophil-mediated trogoptosis and enhances antigen cross-prese...

por Hendriks, Mark A. J. M., Ploeg, Emily M., Koopmans, Iris, Britsch, Isabel, Ke, Xiurong, Samplonius, Douwe F., Helfrich, Wijnand
Publicado 2020

Programmed Death Ligand 1 (PD-L1)-targeted TRAIL combines PD-L1-mediated checkpoint inhibition with TRAIL-mediated apoptosis induction

por Hendriks, Djoke, He, Yuan, Koopmans, Iris, Wiersma, Valerie R., van Ginkel, Robert J., Samplonius, Douwe F., Helfrich, Wijnand, Bremer, Edwin
Publicado 2016

A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

por Koopmans, Iris, Hendriks, Djoke, Samplonius, Douwe F., van Ginkel, Robert J., Heskamp, Sandra, Wierstra, Peter J., Bremer, Edwin, Helfrich, Wijnand
Publicado 2018